TNF alpha is a protein that is produced during the inflammatory response. It both starts as well as perpetuates inflammation. Increased levels of TNF are found in several inflammatory conditions including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Drugs that block tumor necrosis factor (TNF) have been found to be particularly effective for the treatment of these serious types of inflammatory arthritis.
Infliximab (Remicade) is a monoclonal chimeric antibody (part human, part mouse) directed against TNF alpha.
Infliximab is approved for use alone or combined with methotrexate for treating moderate to severe rheumatoid arthritis. It also is approved for the treatment of active psoriatic arthritis and ankylosing spondylitis.
Infliximab is administered intravenously. The recommended dose for the treatment of rheumatoid arthritis is 3 mg/kg as a single dose. The initial dose should be followed by additional 3 mg/kg doses two and six weeks after the first dose. The maintenance dose depends on the patients response. It can be increased to a maximum of 10 mg/kg every 4 weeks.
The most common side effects of infliximab are upper respiratory tract infections, urinary tract infections, cough, rash, back pain, nausea, vomiting, abdominal pain, headache, weakness and fever. Infusion reactions, which are sometimes severe, may occur.
Side effects such as blood pressure changes, chest pain, shortness of breath, rash, itching, fever and chills may occur during or shortly after administration. These reactions could possibly be due to an allergy to the drug. They are more common among patients who develop antibodies to infliximab and are less likely to occur in patients who are taking drugs that suppress the immune system, such as methotrexate. Infliximab should be discontinued if serious reactions occur.
Serious infections have been reported with other drugs that block TNF- alpha, and infections have been reported during treatment with infliximab. Therefore, infliximab should not be used in patients with serious infections. Infliximab should be discontinued if a serious infection develops during treatment.
Before starting infliximab, persons should have tuberculosis skin testing, because of reports of reactivation of tuberculosis in patients taking infliximab.
There have been rare cases of serious liver injury in people taking infliximab. Screening for hepatitis B may be a good idea.
Infliximab should not be used in patients with congestive heart failure or other significant heart disease.
Approximately half of infliximab-treated patients in clinical trials developed a positive ANA during the trial compared with approximately one-fifth of placebo-treated patients. Anti-dsDNA antibodies were newly detected in approximately one-fifth of infliximab-treated patients compared with 0% of placebo-treated patients. Reports of lupus and lupus-like syndromes, however, remain uncommon.
Decreased white and red blood cell and decreased platelet counts have been reported with infliximab. Vasculitis (inflammation of arteries) also has been reported.
Patients with rheumatoid arthritis, particularly patients with very active disease and/or chronic exposure to immunosuppressive therapies, may be at a higher risk (up to several fold) than the general population for the development of lymphoma. It is not known whether anti-TNF therapy raises this level of risk.
Infliximab should not be used in combination with anakinra (Kineret).
Dr. Wei (pronounced way) is a board-certified rheumatologist and Clinical Director of the nationally respected Arthritis and Osteoporosis Center of Maryland. He is a Clinical Assistant Professor of Medicine at the University of Maryland School of Medicine and has served as a consultant to the Arthritis Branch of the National Institutes of Health. He is a Fellow of the American College of Rheumatology and the American College of Physicians. For more information on arthritis and related conditions, go to: Arthritis Treatment
My Doctor Wants Me To Start Kineret For My Rheumatoid Arthritis - What Is It?
Kineret the chemical name is anakinra- is a biologic drug that blocks the effects of interleukin 1. Interleukin 1 is a protein that is produced in excess in people with rheumatoid arthritis (RA). It, along with tumor necrosis factor (TNF), seem to...
Rheumatoid Arthritis Treatment: Alternatives And Medication
Rheumatoid arthritis treatment is a necessary yet complex process. There are many aspects that need to be taken into consideration in this fight against your own body. The first step is to see your doctor. There are several forms of arthritis, one...
Rheumatoid Arthritis And Getting Help
If you suffer from rheumatoid conditions like that of arthritis, it is increasingly important for you to get the help that you need in dealing with this condition. Although there are many people that dont get the help they need, if you do, you will ...
What Is Voice Box Arthritis?
Most people think rheumatoid arthritis affects only the small joints of the hands of feet. However, any joints in the body that contain cartilage and synovial fluid are targets for the disease.Small joints in the voice box can be affected by arthrit...
What Are Palindromic Rheumatoid Arthritis Symptoms
Palindromic rheumatoid arthritis disease is whereby you experience periodic episodes of pain, swelling, warmth, and stiffness of joints. You have recurrent attacks of transient inflammation in and around the joint. The pain is usually focused on tw...
My Rheumatologist Wants Me to Take Rituxan What is It?
Rituxan is the trade name for rituximab. This a human/mouse monoclonal antibody It targets a marker called CD20 which is located on the cell surface of B lymphocytes, white blood cells that are felt to be important in promoting the inflammation o...
Drugs Usage For Arthritis And Its Side Effects
Mangosteen supplementation may also be helpful in preventing the side effects associated with the stronger drugs used to treat the more severe rheumatoid arthritis symptoms, because of anti-oxidants, vitamins and minerals found in the fruit. Boswelli...
What You Can Do About Arthritis Pain
In most forms of arthritis, the first treatments are aimed at relieving the symptoms such as pain, inflammation, and stiffness. Patients usually take arthritis pain medication over several years, especially in chronic inflammatory cases. There are se...
Rheumatoid Arthritis And Medications
There is an array of prescription arthritis medications which health professionals can provide to help with rheumatoid arthritis. While these arthritis medications may not cure, they can bring pain relief, alleviate symptoms, and even slow the progre...
Are The New Biologic Drugs For Rheumatoid Arthritis Worth The Cost?
The standard beginning therapy for rheumatoid arthritis (RA) consists of methotrexate as a disease modifying anti-rheumatic drug (DMARD) and either a non-steroidal anti-inflammatory drug (NSAID) or low dose prednisone. While these drugs do work to a...
